• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Treatment of bipolar depression: a survey of Canadian psychiatrists.

作者信息

Sharma V, Mazmanian D S, Persad E, Kueneman K M

机构信息

Mood Disorders Unit, London Psychiatric Hospital, Ontario.

出版信息

Can J Psychiatry. 1997 Apr;42(3):298-302. doi: 10.1177/070674379704200308.

DOI:10.1177/070674379704200308
PMID:9114946
Abstract

OBJECTIVE

This study was conducted to examine how Canadian psychiatrists manage bipolar depression.

METHOD

A questionnaire specific to the treatment of bipolar depression was mailed to 1639 active members of the Canadian Psychiatric Association.

RESULTS

Seven hundred and sixty-six completed questionnaires were returned (46.7%). Most psychiatrists indicated that a combination of psychotherapy and somatic therapy was their preferred approach. For bipolar disorder, depressed, lithium carbonate and selective serotonin reuptake inhibitors (SSRIs) were the preferred treatment strategies. For substitution, tricyclic antidepressants (TCAs) were the favoured choice. Lithium carbonate was the preferred choice for augmentation and, addition.

CONCLUSION

These findings indicate that a combination of psychotherapy and somatic therapy is the preferred treatment approach for bipolar depression. Lithium carbonate and SSRIs are the favoured somatic therapies.

摘要

相似文献

1
Treatment of bipolar depression: a survey of Canadian psychiatrists.
Can J Psychiatry. 1997 Apr;42(3):298-302. doi: 10.1177/070674379704200308.
2
Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants.选择性5-羟色胺再摄取抑制剂和三环类抗抑郁药引发的躁狂症
Br J Psychiatry. 1994 Apr;164(4):549-50. doi: 10.1192/bjp.164.4.549.
3
Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants.伴有抑郁特征的重度抑郁症的药物治疗:三环类与选择性5-羟色胺再摄取抑制剂抗抑郁药的相对疗效
J Affect Disord. 1996 Jun 20;39(1):1-6. doi: 10.1016/0165-0327(96)00014-6.
4
Developments in the drug treatment of panic disorder: what is the place of the selective serotonin reuptake inhibitors?惊恐障碍药物治疗的进展:选择性5-羟色胺再摄取抑制剂的地位如何?
J Affect Disord. 1996 Sep 9;40(1-2):85-93. doi: 10.1016/0165-0327(96)00043-2.
5
Rational polypharmacy in the bipolar affective disorders.双相情感障碍中的合理联合用药
Epilepsy Res Suppl. 1996;11:153-80.
6
Efficacy, safety and tolerability of combined administration of lithium and selective serotonin reuptake inhibitors: a review of the current evidence. Hertfordshire Neuroscience Research Group.锂盐与选择性5-羟色胺再摄取抑制剂联合使用的疗效、安全性及耐受性:现有证据综述。赫特福德郡神经科学研究小组
Int Clin Psychopharmacol. 2000 Jul;15(4):197-206. doi: 10.1097/00004850-200015040-00002.
7
Preventive Effects of Lithium Carbonate on Antidepressant-Induced Switch During Depressive Episodes: Chinese Data Analysis.碳酸锂预防抑郁发作期抗抑郁药诱发转相的效果:中国数据分析。
Altern Ther Health Med. 2022 Jan;28(1):58-64.
8
Antidepressant-associated chronic irritable dysphoria (acid) in bipolar disorder: a case series.双相情感障碍中与抗抑郁药相关的慢性激惹性烦躁不安(酸):病例系列
J Affect Disord. 2005 Feb;84(2-3):267-72. doi: 10.1016/j.jad.2004.08.004.
9
Treatment of severe depression with the selective serotonin reuptake inhibitors.使用选择性5-羟色胺再摄取抑制剂治疗重度抑郁症。
Depress Anxiety. 1996;4(4):182-9. doi: 10.1002/(SICI)1520-6394(1996)4:4<182::AID-DA4>3.0.CO;2-H.
10
Treatment options in the management of adolescent depression.青少年抑郁症管理中的治疗选择。
J Affect Disord. 2000 Dec;61 Suppl 1:23-8. doi: 10.1016/s0165-0327(00)00286-x.

引用本文的文献

1
Pragmatic issues and prescribing patterns in bipolar disorder: A mental health professional's survey.双相情感障碍中的实际问题与处方模式:一项心理健康专业人员的调查。
Ind Psychiatry J. 2022 Jul-Dec;31(2):235-242. doi: 10.4103/ipj.ipj_22_21. Epub 2022 Aug 18.